Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss

Obesity

Volumn 16, Issue 7, 2008, Pages 1516-1521

  Rasmussen, Michael H ^a   Wildschiødtz, Gordon ^a   Juul, Anders ^a   Hilsted, Jannik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; IGFBP3 PROTEIN, HUMAN; INSULIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; LEPTIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD; CALORIC INTAKE; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; REM SLEEP; SLEEP; SLEEP DISORDER; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; ENERGY INTAKE; FEMALE; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; OBESITY; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP DISORDERS; SLEEP, REM; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 46249128864     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.249     Document Type: Article

References (44)

1. Gangwish JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289-1296.
2. Meisinger C, Heier M, Loewel H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005;48:235-241.
3. Dixon JB, Dixon ME, Anderson ML, Schachter, O'Brien PE. Daytime sleepiness in the obese: not as simple as obstructive sleep apnea. Obesity 2007;15:2504-2511.
4. Cauter EV, Holmbäck U, Knutson K et al. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 2007;67(Suppl 1):2-9.
5. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:210-217.
6. Cauter EV, Plat L, Copinschi G. Interrelations between sleep and the somatotropic axis. Sleep 1998;21:553-566.
7. Redwine L, Hauger RL, Gillin C, Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000;85:3597-3603.
8. Brandenberger G, Gronfier C, Chapotot F, Simon C, Piquard F. Effect of sleep deprivation on overall 24 h growth hormone secretion. Lancet 2000;356:1408-1409.
9. Cauter EV, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000;284:861-868.
10. Cauter EV, Copinschi G. Interactions between growth hormone secretion and sleep. In: Smith RG, Thorner MO (eds). Human Growth Hormone: Research and Clinical Practice. Humana Press: Totowa, NJ, 2000, pp 261-284.
11. Brandenberger G, Weibel L. The 24-h growth hormone rhythm in men: sleep and circadian influences questioned. J Sleep Res 2004;13:251-255.
12. Rasmussen MH, Hvidberg A, Juul A et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80:1407-1415.
13. De Marinis L, Bianchi A, Mancini A et al. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: realtionships with insulin and body composition. J Clin Endocrinol Metab 2004;89:174-180.
14. Cauter EV, Polonsky KS, Blackman JD et al. Abnormal temporal patterns of glucose tolerance in obesity: relationships to sleep-related growth hormone secretion and circadian cortisol rhythmicity. J Clin Endocrinol Metab 1994;79:1797-1805.
15. Prinz PN, Moe KE, Dulberg EM et al. Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men. J Gerontol A Biol Sci Med Sci 1995;50:M222-M226.
16. Spiegel K, Leproult R, Cauter EV. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439.
17. Spiegel K, Leproult R, L'Hermite-Baléiaux M, Copinschi G, Penev RD, Cauter EV. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol and thyrotropin. J Clin Endocrinol Metab 2004;89:5762-5771.
18. Rechtschaffen A, Kales A. A Manual of Standardized Terminology Techniques and Scoring Systems for Sleep Stages of Human Subjects. UCLA Brain Information service/Brain Research Institute: Los Angeles, 1968.
19. Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
20. Rasmussen MH, Juul A, Hilsted J. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Obesity 2007;15:879-886.
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
22. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese subjects. Arch Intern Med 1994;154:1705-1711.
23. Resta O, Barbaro MPF, Bonfitto P et al. Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 2003;253:536-543.
24. Sassin JF, Parker DC, Mace JW, Gotlin RW, Johnson JC, Rossman LG. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science 1969;165:513-515.
25. Nindl BC, Rarick KR, Castellani JW et al. Altered secretion of growth hormone and luteinzing hormone after 84 h of sustained physical exertion superimposed on caloric and sleep restriction. J Appl Physiol 2006;100:120-128.
26. Obál F Jr, Kapás L, Bodosi B, Krueger JM. Changes in sleep in response to intracerebral injection of insulin-like growth factor-1 (IGF-1) in the rat. Sleep Res Online 1998;1:87-91.
27. Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 2005;1037:204-208.
28. Ursavas A, Karadag M, Ilcol YO et al. Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome. Lung 2007;185:309-314.
29. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004;14:337-375.
30. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3 and growth hormone. Metabolism 1994;43:315-319.
31. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res 2004;14:91-96.
32. Lukanova A, Söderberg S, Stattin P et al. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 2002;13:509-516.
33. Schneider HJ, Saller B, Klotsche J et al. Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 2006;54:699-706.
34. Gram IT, Norat T, Dossus L et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes 2006;30:1623-1631.
35. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Warreham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-1745.
36. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease. Circulation 2002;106:939-944.
37. Littman AJ, Vitiello MV, Foster-Schubert KF et al. Sleep ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes 2007;31:466-475.
38. Björntorp P. Visceral obesity: "a civilization syndrome." Obes Res 1993;1:206-222.
39. Vgontzas AN, Pejovic S, Zoumakis E et al. Hypothalamic-pituitary- adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Metab Endocrinol 2007;92:4199-4207.
40. Vgontzas AN, Zoumakis E, Bixler EO et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-2126.
41. Street ME, Ziveri MA, Spaggiari C et al. Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur J Endocrinol 2006;154:47-52.
42. Vgontzas AN, Trakada G, Bixler EO et al. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism 2006;55:1076-1082.
43. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007;167:31-39.
44. Vilarrasa N, Vendrell J, Sánchez-Santos R et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese subjects. Clin Endocrinol (Oxf) 2007;67:679-686.